The emerging HEVC standard supports up to 12 variable block sizes ranging from 4x8/8x4 to 64x64 to conduct motion estimation (ME) and motion compensation (MC). This feature contributes considerable coding gain compared with 7 variable block sizes in H.264/A VC at the cost of huge computational complexity. In the test model HM, ME with variable block sizes (VBSME) may be called up to 425 times for the mode decision procedure of one CTU (Coding Tree Unit). Obviously, VBSME becomes the bottleneck for real time encoding. In this paper, we focus on parallel realization architecture design of VBSME in HEVC. Firstly, an efficient parallel encoder framework is proposed for CPU plus GPU platform. With the framework, VBSME, fractional-pixel image interpolation and border padding processes run on GPU without burden on the host CPU. Secondly, for workload balance between CPU and GPU, a fast Prediction Unit partition mode decision algorithm is also proposed. Lastly, the parallel realization strategy of VBSME on GPU is improved for ME compression performance improvement. Experimental results based on the NVIDIA's C2050 GPU show that the speed of the VBSME strategy on GPU is about 113 times faster than the one on CPU.
A large number of studies have shown that the variation and disorder of miRNAs are important causes of diseases. The recognition of disease-related miRNAs has become an important topic in the field of biological research. However, the identification of disease-related miRNAs by biological experiments is expensive and time consuming. Thus, computational prediction models that predict disease-related miRNAs must be developed. A novel network projection-based dual random walk with restart (NPRWR) was used to predict potential disease-related miRNAs. The NPRWR model aims to estimate and accurately predict miRNA–disease associations by using dual random walk with restart and network projection technology, respectively. The leave-one-out cross validation (LOOCV) was adopted to evaluate the prediction performance of NPRWR. The results show that the area under the receiver operating characteristic curve(AUC) of NPRWR was 0.9029, which is superior to that of other advanced miRNA–disease associated prediction methods. In addition, lung and kidney neoplasms were selected to present a case study. Among the first 50 miRNAs predicted, 50 and 49 miRNAs have been proven by in databases or relevant literature. Moreover, NPRWR can be used to predict isolated diseases and new miRNAs. LOOCV and the case study achieved good prediction results. Thus, NPRWR will become an effective and accurate disease–miRNA association prediction model.
Recent studies indicated that numerous long noncoding RNAs (lncRNAs) are closely related to human diseases and can serve as potential biomarkers and drug targets for complex diseases. Therefore, identifying lncRNAs associated with diseases through computational methods is conducive to the exploration of disease pathogenesis. Most previous studies had shortcomings, such as low prediction accuracy, the need for negative samples, and weak generalization. Such studies established shallow prediction models and failed to fully capture the complex relationships among lncRNA-disease associations, lncRNA similarity, and disease similarity. LRLSSP, a new computational method based on Laplacian regularized least squares (LRLS) and space projection was used to predict candidate disease lncRNAs in this study. LRLSSP deeply integrates information on lncRNA similarity, disease similarity, and known lncRNA-disease associations. The estimated score of lncRNA-disease association was obtained through LRLS, and network projection was utilized to reliably predict disease-related lncRNAs. Leave-oneout cross validation(LOOCV) was implemented to evaluate the prediction performance of LRLSSP. Results showed that LRLSSP performed was better than other state-of-the-art methods in predicting lncRNAdisease associations. In addition, case studies conducted on melanoma,cervical cancer, ovarian cancer and breast cancer indicated that LRLSSP can discover potential and novel lncRNA-disease associations. Overall, the results demonstrated that LRLSSP may serve as a reliable and effective computational tool for disease-related lncRNAs prediction.
Spectrum is a kind of non-reproducible scarce strategic resource. A secure wideband spectrum sensing technology provides the possibility for the next generation of ultra-dense, ultra-large-capacity communications to realize the shared utilization of spectrum resources. However, for the open collaborative sensing in cognitive radio networks, the collusion attacks of malicious users greatly affect the accuracy of the sensing results and the security of the entire network. To address this problem, this paper proposes a weighted fusion decision algorithm by using the blockchain technology. The proposed algorithm divides the single-node reputation into active reputation and passive reputation. Through the proposed token threshold concept, the active reputation is set to increase the malicious cost of the node; the passive reputation of the node is determined according to the historical data and recent performance of the blockchain. The final node weight is obtained by considering both kinds of reputation. The proposed scheme can build a trust-free platform for the cognitive radio collaborative networks. Compared with the traditional equal-gain combination algorithm and the centralized sensing algorithm based on the beta reputation system, the simulation results show that the proposed algorithm can obtain reliable sensing results with a lower number of assistants and sampling rate, and can effectively resist malicious users’ collusion attacks. Therefore, the security and the accuracy of cooperative spectrum sensing can be significantly improved in cognitive radio networks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.